Navigation Links
FDA Advisers Urge Infant Doses for Kids' OTC Fever Relievers

By Jenifer Goodwin
HealthDay Reporter

WEDNESDAY, May 18 (HealthDay News) -- U.S. health advisers recommended Wednesday that dosing instructions should be added to the labels of medicines containing the widely used pain reliever and fever reducer acetaminophen to better protect children under the age of 2.

In a 21-0 vote, the panel of U.S. Food and Drug Administration advisers called for adding dosing information for children 6 months to 2 years old to over-the-counter medicines such as Children's Tylenol and similar products containing acetaminophen, the Associated Press reported.

Currently, the labels of such medications have dosing instructions for children aged 2 and up. For kids under 2, the labels on the liquid medicines simply tell parents to "ask a doctor."

The FDA advisers said the lack of specific dosing recommendations can lead to confusion, with parents unintentionally giving too much of the medicine to children under age 2. Acetaminophen-related overdoses are most common among children younger than 2, and have increased over the past decade, according to FDA data.

Wednesday's vote focused only on a small group of single-ingredient products, including J&J's Children and Infants' Tylenol, Novartis' Triaminic, Prestige Brands' Little Fevers and assorted drugstore brands, the AP said.

In a second vote Wednesday, the panel recommended unanimously that these medicines should also include dosing information based on children's weight -- considered the most accurate way to determine the proper dose. Nearly all over-the-counter manufacturers already include a dosing table with both weight and age. But the FDA advisers said instructions must emphasize that weight is the preferred approach, the AP reported.

In a third vote, the advisers recommended 17-3, with one abstention, that the FDA consider requiring a single dosage for children's solid acetaminophen tablets, the news service said.

While the FDA is not required to follow the recommendations of its advisory panels, it usually does so.

The American Academy of Pediatrics (AAP) and drug manufacturers are both strongly in favor of giving parents the additional dosing information.

"If we give parents better information, they will be able to give enough of the medicine to work well, at the same time minimizing the side effects," said Dr. Daniel Frattarelli, a pediatrician in Dearborn, Mich., who chairs the academy's drug committee and who planned to testify before the joint, two-day meeting of the FDA's Nonprescription Drugs Advisory Committee and the Pediatric Advisory Committee.

"Parents want to do the right thing for their children," he said. "We as a medical community have to give them that information so they are able to do this."

Although the evidence shows that acetaminophen is safe for young children, parents have to be careful with it, pediatricians noted. Giving too much can be toxic to the liver, causing poisoning and even liver failure.

In 2010, there were 270,000 reported overdoses of acetaminophen, according to the American Association of Poison Control Centers. Dosing errors involving children's acetaminophen products accounted for almost 7,500 cases -- nearly 3 percent.

In an ideal world, the parents of infants and toddlers would still consult with their pediatrician or pharmacist to get the proper medication dosing, said Dr. William Basco, director of general pediatrics at the Medical University of South Carolina.

But the reality is that many parents aren't doing that and are instead guessing about proper dosing. "There is no benefit to having parents guess at the right dose," Basco said.

Drug makers, including McNeil Consumer Healthcare, which makes Tylenol, also support the change.

"McNeil is committed to encouraging the appropriate and safe use of medicines in children, including adding new dosing information on the OTC pediatric acetaminophen label to assist caregivers and health-care providers in appropriately dosing children, especially those 6 to 23 months of age," the company wrote in materials submitted to the FDA.

By way of comparison, drugs containing ibuprofen -- another heavily used over-the-counter fever reducer -- already include dosing information for children under age 2.

Children's medications containing acetaminophen have been sold over-the-counter since 1959, and dosing information for children has been on the labels since the 1970s, according to McNeil.

Back then, doses for kids were somewhat crude -- children 12 and up were advised to take the adult dose, kids 6 to 12 were told to take half that, and kids younger than 6 were told to take a quarter of the adult dose.

Since then, as physicians have learned more about the medications, dosing recommendations for infants and toddlers have become more refined and now should be based on weight, not age, according to the AAP. (Age is still listed on package labeling, the AAP explained.) Kids' weights can range widely at any given age, so the correct dose for a child on the heavier side may not be the correct dose for a smaller child of the same age.

Though acetaminophen is safe even in newborns if used correctly, the drug makers and the AAP called for expanding the labeling information for children 6 months old and up.

Parents should still be encouraged to consult with their physicians before giving medication to younger children, especially those under the age of 3 months, Frattarelli said. Fevers of more than 100.4 degrees need to be taken very seriously in infants, whose immune systems are not fully developed and whose vaccinations haven't yet fully kicked in, he explained.

Earlier this month, the Consumer Healthcare Products Association, a trade association for over-the-counter drug-makers, agreed to sell only one concentration of acetaminophen in products for infants and children to prevent dosing errors.

Previously, for example, Infant's Tylenol liquid drops were much more concentrated than Children's Tylenol, which could easily lead to confusion if parents didn't read the label or know there was a difference.

Drug-makers agreed to phase out the infant drops concentration starting in the middle of this year.

In any given week, about 23 percent of kids under age 2 are given acetaminophen, according to background information from McNeil.

"Acetaminophen dosing errors are a rare but potentially very severe adverse event that could lead to liver failure or even death for kids," said Dr. Richard Dart, president of the American Association of Poison Control Centers, in a news release. "This decision will lessen the chance that parents will give their children the wrong dose."

More information

The U.S. Food and Drug Administration has more on giving over-the-counter medications to children.

SOURCES: William Basco, M.D., director, general pediatrics, Medical University of South Carolina, Charleston; Daniel Frattarelli, M.D., pediatrician, Dearborn, Mich., and chair, American Academy of Pediatrics Committee on Drugs; U.S. Food and Drug Administration Web site; Associated Press

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. FDA Advisers Renew Review on Whether to Ban Menthol Cigarettes
2. FDA Advisers Endorse New Lupus Drug
3. FDA Advisers Consider New Lupus Drug
4. FDA Advisers Back Anemia Drugs for Kidney Patients
5. FDA Advisers Consider Approval of Genetically Modified Salmon
6. FDA Advisers Weigh Approval of Genetically Modified Salmon
7. FDA Advisers Divided on Whether to Ban Diet Drug Meridia
8. FDA Advisers Say Avastin Shouldnt Be Used for Breast Cancer
9. FDA to Broaden Disclosure on Advisers Conflicts of Interest
10. FDA Advisers Urge Stricter Regulation of Tanning Beds
11. Electronic medical records lower infant mortality, study finds
Post Your Comments:
Related Image:
FDA Advisers Urge Infant Doses for Kids' OTC Fever Relievers
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... Florida Hospital Tampa is the ... of obesity in the state of Florida. , vBloc® Therapy is a vagal blocking therapy, ... 18 years with a body mass index (BMI) of at least 40 to 45 kg, ...
(Date:12/1/2015)... ... December 01, 2015 , ... Califia Farms , ... that its iconic bottle has won top honors in Beverage World Magazine’s Global Packaging ... also announced that it has been selected as a 2015 U.S.A. Taste Champion in ...
(Date:12/1/2015)... ... December 01, 2015 , ... December 1, ... expansion of the company’s growing product line of food safety and seafood fraud ... Sockeye (Oncorhynchus nerka) – allow InstantLabs to offer fast, reliable species identification for ...
(Date:12/1/2015)... ... December 01, 2015 , ... The ... been lifted as IMAGE Information Systems launches MED-TAB™ -- the world’s first portable ... Meeting from November 29 to December 4, 2015. , MED-TAB is expected ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... is everything. That is why Hollister Incorporated has launched the VaPro Plus Pocket™ ... next product in the VaPro touch free catheter portfolio,” said Michael Gresavage, Vice ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... Dec. 1, 2015 As enforcement of the ... Security Act (DSCSA) approaches, InfiniTrak announced ... pharmacies comply with looming FDA regulations. ... entering endorsement agreements with State Pharmacy Associations, an ... organization (PSAO) to exclusively provide the InfiniTrak track-and-trace ...
(Date:12/1/2015)... CLEVELAND , Dec. 1, 2015   ... innovation firm, today announced the publication of a ... Entering the Direct-to-Consumer Medical Market". The whitepaper gives ... roadmap for successfully penetrating this lucrative segment. ... purchase healthcare products to manage their own health, ...
(Date:12/1/2015)... 2015 --> --> ... Market by Type of Drug (Monoclonal Antibodies, Interferon-Alpha, Interleukins, Vaccines, ... Pipeline Analysis - Global Forecast to 2020", published by MarketsandMarkets, ... 73,529.2 Million by 2020 from USD 40,281.6 Million in 2015, ... Browse 37 market data T ...
Breaking Medicine Technology: